Immunohistochemical imaging of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptors (HER2s) in breast cancers provided further possibilities to clarify the risk factors and therapeutic possibilities of variously differentiated tumors [40]. This evidence concerns the gene PGR and breast carcinoma.